INS and glucose metabolism disease: Prolonged high insulin levels caused by IR and tissue glucose metabolism disorders can lead to systemic metabolic dysfunction, including metabolic disorders associated with fatty liver disease and type 2 diabetes as well as increased mortality associated with diabetes over the long term; 2.